Hermes Pharma, the leading expert in user-friendly oral dosage forms, has been instrumental in developing and manufacturing various dosage forms such as effervescent and chewable tablets, instant drinks, lozenges, and orally disintegrating granules for over 40 years. The company collaborates with healthcare firms globally, aiding them in expanding their product lines and enhancing their brands. Hermes Pharma's spectrum of services covers expert guidance and tailored solutions across the pharmaceutical value chain, spanning from new product development and formulation to manufacturing and regulatory support. Hermes Arzneimittel, the sister company of Hermes Pharma, boasts a rich portfolio of successful OTC brands and a history of pharmaceutical excellence spanning over a hundred years. This legacy positions Hermes Pharma as a reliable and experienced partner well-versed in comprehending the challenges faced by its clients. Founded in 1907, the company operates in the Biotechnology, Manufacturing, and Pharmaceutical sectors, illustrating its diverse expertise and market presence. Hermes Pharma's impactful role in the pharmaceutical industry warrants attention from venture capital investors seeking opportunities in the biotechnology and pharmaceutical sectors. With its extensive experience, reliable track record, and diverse product offerings, Hermes Pharma presents itself as a potential investment prospect for those keen on contributing to the further development and growth of user-friendly oral dosage forms.
There is no investment information
No recent news or press coverage available for HERMES PHARMA - Get the dose right.